Remedy Plan

Developing first-in-class NAMPT inhibitors for oncology, autoimmune, and metabolic diseases

placeWashington, DC, District Of Columbia, United States calendar_todayFounded 2011 groups10 employees language remedyplan.com

Social engagement

Social engagement: 1.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Private equity150%
Other / undisclosed150%

Recent activity

8 Apr 2026
Leadership hire
Chief Financial and Business Officer
29 Dec 2025
Event
J.P. Morgan Healthcare Conference
11 Dec 2025
Event
American Society of Hematology #ASH25
Coming soon